(Q46463152)

22 December 2017

title

Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections (English)

1 reference

22 December 2017

1 reference

1 reference

J Majcher-Peszynska

1

1 reference

22 December 2017

G Haase

2

1 reference

22 December 2017

M Sass

3

1 reference

22 December 2017

R Mundkowski

4

1 reference

22 December 2017

A Pietsch

5

1 reference

22 December 2017

S Klammt

6

1 reference

22 December 2017

W Schareck

7

1 reference

22 December 2017

B Drewelow

8

1 reference

22 December 2017

publication date

25 July 2008

1 reference

22 December 2017

European Journal of Clinical Pharmacology

published in

1 reference

22 December 2017

volume

64

1 reference

22 December 2017

issue

11

1 reference

22 December 2017

page(s)

1093-1100

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s00228-008-0531-5

exact match

0 references

cites work

Intrapulmonary penetration of linezolid

1 reference

12 December 2020

Linezolid penetration into osteo-articular tissues

1 reference

12 December 2020

Uptake and intracellular activity of linezolid in human phagocytes and nonphagocytic cells.

1 reference

12 December 2020

Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid

1 reference

12 December 2020

Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections

1 reference

12 December 2020

Clinical efficacy and antimicrobial pharmacodynamics.

1 reference

12 December 2020

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy

1 reference

12 December 2020

Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses.

1 reference

12 December 2020

Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem

1 reference

12 December 2020

Effects of hyperglycemia on interdigestive gastrointestinal motility in humans.

1 reference

12 December 2020

Determination of antibiotic drug concentrations in circulating human blood by means of solid phase micro-extraction.

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections

1 reference

12 December 2020

Linezolid levels in pancreatic secretions

1 reference

12 December 2020

Pharmacokinetics of linezolid in subjects with renal dysfunction

1 reference

12 December 2020

Determination of linezolid in plasma by reversed-phase high-performance liquid chromatography

1 reference

12 December 2020

Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration

1 reference

12 December 2020

Pharmacokinetics, toxicokinetics, distribution, metabolism and excretion of linezolid in mouse, rat and dog.

1 reference

12 December 2020

Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection?

1 reference

12 December 2020

Diagnosis and treatment of diabetic foot infections

1 reference

12 December 2020

Tissue pharmacokinetics of levofloxacin in human soft tissue infections

1 reference

12 December 2020

Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate

1 reference

12 December 2020

In vivo pharmacodynamics of a new oxazolidinone (linezolid)

1 reference

12 December 2020

Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis

1 reference

12 December 2020

Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock

1 reference

12 December 2020

Target site penetration of fosfomycin in critically ill patients

1 reference

12 December 2020

Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic factors influencing emergence of resistance to linezolid in an in vitro model

1 reference

12 December 2020

Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers

1 reference

12 December 2020

Intrapulmonary pharmacokinetics of linezolid

1 reference

12 December 2020

Microdialysis for in vivo pharmacokinetic/pharmacodynamic characterization of anti-infective drugs

1 reference

12 December 2020

Pharmacokinetics and tissue penetration of linezolid following multiple oral doses

1 reference

12 December 2020

Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis

1 reference

12 December 2020

Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement

1 reference

12 December 2020

Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases.

1 reference

12 December 2020

Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections

1 reference

12 December 2020

Hyperglycaemia and absorption of sulphonylurea drugs

1 reference

12 December 2020

10.1007/S00228-008-0531-5

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

18654767

1 reference

22 December 2017